| 000 | 01820 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517230606.0 | ||
| 264 | 0 | _c20180924 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1943-572X | ||
| 024 | 7 |
_a10.1177/0003489418788112 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeffernan, Colleen B | |
| 245 | 0 | 0 |
_aDoes Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children. _h[electronic resource] |
| 260 |
_bThe Annals of otology, rhinology, and laryngology _cOct 2018 |
||
| 300 |
_a687-693 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 | _aAudiometry, Pure-Tone |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aClarithromycin _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 |
_aHearing _xdrug effects |
| 650 | 0 | 4 |
_aHearing Loss _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLymphadenitis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMycobacterium Infections, Nontuberculous _xdrug therapy |
| 650 | 0 | 4 | _aNeck |
| 650 | 0 | 4 |
_aNontuberculous Mycobacteria _xisolation & purification |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aMcKeon, Mallory G | |
| 700 | 1 | _aMolony, Sasha | |
| 700 | 1 | _aKawai, Kosuke | |
| 700 | 1 | _aStiles, Derek J | |
| 700 | 1 | _aLachenauer, Catherine S | |
| 700 | 1 | _aKenna, Margaret A | |
| 700 | 1 | _aWatters, Karen | |
| 773 | 0 |
_tThe Annals of otology, rhinology, and laryngology _gvol. 127 _gno. 10 _gp. 687-693 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0003489418788112 _zAvailable from publisher's website |
| 999 |
_c28656405 _d28656405 |
||